Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife

Longitudinal associations

R. P. Wildman, P. Mancuso, C. Wang, M. Kim, P. E. Scherer, M. R. Sowers

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: There are limited data concerning the relationships between changes in adipocytokines and cardiovascular disease (CVD) risk factors. Objective: To examine the longitudinal associations between leptin, adiponectin, resistin and ghrelin levels and CVD risk factor levels in women at midlife. Design: Prospective, observational study. Subjects and measurements: Leptin, adiponectin, resistin, ghrelin levels and CVD risk factors were measured in specimens collected from 40 women at 3 points in time corresponding to the pre-, peri- and postmenopause stages of their natural menopause transition. Results: In longitudinal analyses adjusted for CVD risk factors and leptin at the previous menopausal stage, aging, education, smoking and physical activity, greater increases in leptin over the menopause transition were associated with greater decreases in high-density lipoprotein cholesterol (HDL-c) and greater increases in diastolic blood pressure, glucose, insulin and insulin resistance (all P<0.05). Larger decreases in adiponectin over the menopause transition were associated with greater increases in systolic blood pressure, insulin and insulin resistance and with greater decreases in HDL-c. Greater increases in ghrelin levels over the menopausal transition were associated with greater low-density lipoprotein cholesterol increases (P=0.014). Resistin was not associated with CVD risk factor changes. Conclusion: There were significant adverse associations of adipocytokines and ghrelin with multiple CVD risk factor changes in women across midlife. Given that this time period is dynamic for CVD risk, these data underscore the need for additional prospective studies.

Original languageEnglish (US)
Pages (from-to)740-748
Number of pages9
JournalInternational Journal of Obesity
Volume32
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

adipokines
ghrelin
Ghrelin
Adipokines
cardiovascular diseases
menopause
Cardiovascular Diseases
risk factors
resistin
Leptin
leptin
Resistin
adiponectin
Adiponectin
Menopause
Blood Pressure
high density lipoprotein cholesterol
insulin resistance
HDL Cholesterol
Insulin Resistance

Keywords

  • Adipocytokines
  • Adiponectin
  • Cardiovascular risk factors
  • Longitudinal
  • Women

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Endocrinology
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife : Longitudinal associations. / Wildman, R. P.; Mancuso, P.; Wang, C.; Kim, M.; Scherer, P. E.; Sowers, M. R.

In: International Journal of Obesity, Vol. 32, No. 5, 05.2008, p. 740-748.

Research output: Contribution to journalArticle

@article{87aaa955d6a049498be2412ac087c710,
title = "Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: Longitudinal associations",
abstract = "Background: There are limited data concerning the relationships between changes in adipocytokines and cardiovascular disease (CVD) risk factors. Objective: To examine the longitudinal associations between leptin, adiponectin, resistin and ghrelin levels and CVD risk factor levels in women at midlife. Design: Prospective, observational study. Subjects and measurements: Leptin, adiponectin, resistin, ghrelin levels and CVD risk factors were measured in specimens collected from 40 women at 3 points in time corresponding to the pre-, peri- and postmenopause stages of their natural menopause transition. Results: In longitudinal analyses adjusted for CVD risk factors and leptin at the previous menopausal stage, aging, education, smoking and physical activity, greater increases in leptin over the menopause transition were associated with greater decreases in high-density lipoprotein cholesterol (HDL-c) and greater increases in diastolic blood pressure, glucose, insulin and insulin resistance (all P<0.05). Larger decreases in adiponectin over the menopause transition were associated with greater increases in systolic blood pressure, insulin and insulin resistance and with greater decreases in HDL-c. Greater increases in ghrelin levels over the menopausal transition were associated with greater low-density lipoprotein cholesterol increases (P=0.014). Resistin was not associated with CVD risk factor changes. Conclusion: There were significant adverse associations of adipocytokines and ghrelin with multiple CVD risk factor changes in women across midlife. Given that this time period is dynamic for CVD risk, these data underscore the need for additional prospective studies.",
keywords = "Adipocytokines, Adiponectin, Cardiovascular risk factors, Longitudinal, Women",
author = "Wildman, {R. P.} and P. Mancuso and C. Wang and M. Kim and Scherer, {P. E.} and Sowers, {M. R.}",
year = "2008",
month = "5",
doi = "10.1038/sj.ijo.0803782",
language = "English (US)",
volume = "32",
pages = "740--748",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife

T2 - Longitudinal associations

AU - Wildman, R. P.

AU - Mancuso, P.

AU - Wang, C.

AU - Kim, M.

AU - Scherer, P. E.

AU - Sowers, M. R.

PY - 2008/5

Y1 - 2008/5

N2 - Background: There are limited data concerning the relationships between changes in adipocytokines and cardiovascular disease (CVD) risk factors. Objective: To examine the longitudinal associations between leptin, adiponectin, resistin and ghrelin levels and CVD risk factor levels in women at midlife. Design: Prospective, observational study. Subjects and measurements: Leptin, adiponectin, resistin, ghrelin levels and CVD risk factors were measured in specimens collected from 40 women at 3 points in time corresponding to the pre-, peri- and postmenopause stages of their natural menopause transition. Results: In longitudinal analyses adjusted for CVD risk factors and leptin at the previous menopausal stage, aging, education, smoking and physical activity, greater increases in leptin over the menopause transition were associated with greater decreases in high-density lipoprotein cholesterol (HDL-c) and greater increases in diastolic blood pressure, glucose, insulin and insulin resistance (all P<0.05). Larger decreases in adiponectin over the menopause transition were associated with greater increases in systolic blood pressure, insulin and insulin resistance and with greater decreases in HDL-c. Greater increases in ghrelin levels over the menopausal transition were associated with greater low-density lipoprotein cholesterol increases (P=0.014). Resistin was not associated with CVD risk factor changes. Conclusion: There were significant adverse associations of adipocytokines and ghrelin with multiple CVD risk factor changes in women across midlife. Given that this time period is dynamic for CVD risk, these data underscore the need for additional prospective studies.

AB - Background: There are limited data concerning the relationships between changes in adipocytokines and cardiovascular disease (CVD) risk factors. Objective: To examine the longitudinal associations between leptin, adiponectin, resistin and ghrelin levels and CVD risk factor levels in women at midlife. Design: Prospective, observational study. Subjects and measurements: Leptin, adiponectin, resistin, ghrelin levels and CVD risk factors were measured in specimens collected from 40 women at 3 points in time corresponding to the pre-, peri- and postmenopause stages of their natural menopause transition. Results: In longitudinal analyses adjusted for CVD risk factors and leptin at the previous menopausal stage, aging, education, smoking and physical activity, greater increases in leptin over the menopause transition were associated with greater decreases in high-density lipoprotein cholesterol (HDL-c) and greater increases in diastolic blood pressure, glucose, insulin and insulin resistance (all P<0.05). Larger decreases in adiponectin over the menopause transition were associated with greater increases in systolic blood pressure, insulin and insulin resistance and with greater decreases in HDL-c. Greater increases in ghrelin levels over the menopausal transition were associated with greater low-density lipoprotein cholesterol increases (P=0.014). Resistin was not associated with CVD risk factor changes. Conclusion: There were significant adverse associations of adipocytokines and ghrelin with multiple CVD risk factor changes in women across midlife. Given that this time period is dynamic for CVD risk, these data underscore the need for additional prospective studies.

KW - Adipocytokines

KW - Adiponectin

KW - Cardiovascular risk factors

KW - Longitudinal

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=43449091901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449091901&partnerID=8YFLogxK

U2 - 10.1038/sj.ijo.0803782

DO - 10.1038/sj.ijo.0803782

M3 - Article

VL - 32

SP - 740

EP - 748

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 5

ER -